Database: Mesotherapy

nvcg1NVCG Commissie Wetenschap

Database: Mesotherapy

 

 

 

  1. Sparavigna, A., B. Tenconi, and I. De Ponti, Antiaging, photoprotective, and brightening activity in biorevitalization: a new solution for aging skin. Clin Cosmet Investig Dermatol, 2015. 8: p. 57-65.
  2. Tedeschi, A., F. Lacarrubba, and G. Micali, Mesotherapy with an Intradermal Hyaluronic Acid Formulation for Skin Rejuvenation: An Intrapatient, Placebo-Controlled, Long-Term Trial Using High-Frequency Ultrasound. Aesthetic Plast Surg, 2014.
  3. Sezgin, B., et al., The Effect of Microneedle Thickness on Pain During Minimally Invasive Facial Procedures: A Clinical Study. Aesthet Surg J, 2014. 34(5): p. 757-765.
  4. Rodriguez-Gutierrez, G., et al., Nocardia brasiliensis infection: an emergent suppurative granuloma after mesotherapy. Int J Dermatol, 2014. 53(7): p. 888-90.
  5. Mammucari, M., et al., Role of the informed consent, from mesotherapy to opioid therapy. Eur Rev Med Pharmacol Sci, 2014. 18(4): p. 566-74.
  6. Iannitti, T., et al., Combination therapy of hyaluronic acid mesotherapic injections and sclerotherapy for treatment of lower leg telangiectasia without major venous insufficiency: a preliminary clinical study. Clin Appl Thromb Hemost, 2014. 20(3): p. 326-30.
  7. Gualdi, G., et al., Acute siliconomas of the face triggered by skin rejuvenation mesotherapy with low weight hyaluronic acid; surgical treatment and pathogenetic hypothesis. G Ital Dermatol Venereol, 2014.
  8. Bulam, H., et al., The Inhibitory Effect of Platelet-Rich Plasma on Botulinum Toxin Type-A: An Experimental Study in Rabbits. Aesthetic Plast Surg, 2014.
  9. Atkins, B.L. and T. Gottlieb, Skin and soft tissue infections caused by nontuberculous mycobacteria. Curr Opin Infect Dis, 2014. 27(2): p. 137-45.
  10. Zaragoza, J., et al., [A rare side effect of mesotherapy: Nicolau syndrome]. Ann Dermatol Venereol, 2013. 140(11): p. 713-7.
  11. Savoia, A., S. Landi, and A. Baldi, A new minimally invasive mesotherapy technique for facial rejuvenation. Dermatol Ther (Heidelb), 2013. 3(1): p. 83-93.
  12. Rodriguez-Gutierrez, G., et al., Nocardia brasiliensis infection: an emergent suppurative granuloma after mesotherapy. Int J Dermatol, 2013.
  13. Park, E.J., et al., Histological changes after treatment for localized fat deposits with phosphatidylcholine and sodium deoxycholate. J Cosmet Dermatol, 2013. 12(3): p. 240-3.
  14. Moftah, N., et al., Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation. J Eur Acad Dermatol Venereol, 2013. 27(6): p. 686-93.
  15. Mammucari, M., et al., [Informed consent and experimental treatments: the case of mesotherapy]. Recenti Prog Med, 2013. 104(5): p. 214-7.
  16. Konda, D. and D.M. Thappa, Mesotherapy: What is new? Indian J Dermatol Venereol Leprol, 2013. 79(1): p. 127-34.
  17. Jayasinghe, S., et al., Mesotherapy for local fat reduction. Obes Rev, 2013.
  18. Baspeyras, M., et al., Clinical and biometrological efficacy of a hyaluronic acid-based mesotherapy product: a randomised controlled study. Arch Dermatol Res, 2013.
  19. Wassef, C. and B.K. Rao, The science of cellulite treatment and its long-term effectiveness. J Cosmet Laser Ther, 2012. 14(2): p. 50-8.
  20. Vukcevic, N.P., et al., Severe acute caffeine poisoning due to intradermal injections: mesotherapy hazard. Vojnosanit Pregl, 2012. 69(8): p. 707-13.
  21. Taieb, M., et al., Hyaluronic acid plus mannitol treatment for improved skin hydration and elasticity. J Cosmet Dermatol, 2012. 11(2): p. 87-92.
  22. Ramos-e-Silva, M., et al., Oleoma: rare complication of mesotherapy for cellulite. Int J Dermatol, 2012. 51(2): p. 162-7.
  23. Mammucari, M., et al., Role of mesotherapy in musculoskeletal pain: opinions from the italian society of mesotherapy. Evid Based Complement Alternat Med, 2012. 2012: p. 436959.
  24. Jager, C., et al., Bioactive reagents used in mesotherapy for skin rejuvenation in vivo induce diverse physiological processes in human skin fibroblasts in vitro- a pilot study. Exp Dermatol, 2012. 21(1): p. 72-5.
  25. El-Domyati, M., et al., Efficacy of mesotherapy in facial rejuvenation: a histological and immunohistochemical evaluation. Int J Dermatol, 2012. 51(8): p. 913-9.
  26. Wongkitisophon, P., et al., Cutaneous Mycobacterium abscessus Infection Associated with Mesotherapy Injection. Case Rep Dermatol, 2011. 3(1): p. 37-41.
  27. Tawfik, H.A., et al., Phosphatidylcholine for the treatment of prominent lower eyelid fat pads: a pilot study. Ophthal Plast Reconstr Surg, 2011. 27(3): p. 147-51.
  28. Sarkar, R., V.K. Garg, and V. Mysore, Position paper on mesotherapy. Indian J Dermatol Venereol Leprol, 2011. 77(2): p. 232-7.
  29. Ramos, A., et al., [Development of subcutaneous nodules after mesotherapy]. Enferm Infecc Microbiol Clin, 2011. 29(10): p. 775-7.
  30. Navarte, D.A. and J. Rosset-Llobet, Safety of subcutaneous microinjections (mesotherapy) in musicians. Med Probl Perform Art, 2011. 26(2): p. 79-83.
  31. Marrif, H.I., Thyroid hormones and mesotherapy. Front Endocrinol (Lausanne), 2011. 2: p. 5.
  32. Mammucari, M., et al., Mesotherapy, definition, rationale and clinical role: a consensus report from the Italian Society of Mesotherapy. Eur Rev Med Pharmacol Sci, 2011. 15(6): p. 682-94.
  33. Kutlubay, Z., Evaluation of mesotherapeutic injections of three different combinations of lipolytic agents for body contouring. J Cosmet Laser Ther, 2011. 13(4): p. 142-53.
  34. Herreros, F.O., A.M. Moraes, and P.E. Velho, Mesotherapy: a bibliographical review. An Bras Dermatol, 2011. 86(1): p. 96-101.
  35. Galmes-Truyols, A., et al., An outbreak of cutaneous infection due to Mycobacterium abscessus associated to mesotherapy. Enferm Infecc Microbiol Clin, 2011. 29(7): p. 510-4.
  36. Galadari, H. and F. Al Faresi, Mesotherapy. Skinmed, 2011. 9(6): p. 342-3.
  37. Duncan, D. and A.M. Rotunda, Injectable therapies for localized fat loss: state of the art. Clin Plast Surg, 2011. 38(3): p. 489-501, vii.
  38. Couderc, C., et al., [Non-tuberculous mycobacterial infections related to esthetic care in France, 2001-2010]. Med Mal Infect, 2011. 41(7): p. 379-83.
  39. Sivagnanam, G., Mesotherapy – The french connection. J Pharmacol Pharmacother, 2010. 1(1): p. 4-8.
  40. Schmutz, J.L., A. Barbaud, and P. Trechot, [Alopecia and mesotherapy]. Ann Dermatol Venereol, 2010. 137(4): p. 338.
  41. Rozhanets, A.R., E.A. Turova, and D.B. Kul’chitskaia, [Combined application of electric myo-stimulation and meso-therapy for the correction of age-related changes of the facial skin]. Vopr Kurortol Fizioter Lech Fiz Kult, 2010(4): p. 26-30.
  42. Rallis, E., et al., Mesotherapy-induced urticaria. Dermatol Surg, 2010. 36(8): p. 1355-6.
  43. Quinones, C., et al., An outbreak of Mycobacterium fortuitum cutaneous infection associated with mesotherapy. J Eur Acad Dermatol Venereol, 2010. 24(5): p. 604-6.
  44. Orjuela, D., et al., Cutaneous tuberculosis after mesotherapy: report of six cases. Biomedica, 2010. 30(3): p. 321-6.
  45. Mysore, V., Mesotherapy in Management of Hairloss – Is it of Any Use? Int J Trichology, 2010. 2(1): p. 45-6.
  46. Kim, J.B., et al., Ischemic colitis after mesotherapy combined with anti-obesity medications. World J Gastroenterol, 2010. 16(12): p. 1537-40.
  47. Hasegawa, T., T. Matsukura, and S. Ikeda, Mesotherapy for benign symmetric lipomatosis. Aesthetic Plast Surg, 2010. 34(2): p. 153-6.
  48. Gutierrez-de la Pena, J., et al., [Three cases of panniculitis due to Mycobacterium abscessus after mesotherapy]. Actas Dermosifiliogr, 2010. 101(2): p. 188-90.
  49. Da Mata Jardin, O., et al., [Follow-up on an outbreak in Venezuela of soft-tissue infection due to Mycobacterium abscessus associated with Mesotherapy]. Enferm Infecc Microbiol Clin, 2010. 28(9): p. 596-601.
  50. Correa, N.E., et al., Outbreak of mesotherapy-associated cutaneous infections caused by Mycobacterium chelonae in Colombia. Jpn J Infect Dis, 2010. 63(2): p. 143-5.
  51. Braccini, F. and D.M. Dohan Ehrenfest, [Advantages of combined therapies in cosmetic medicine for the treatment of face aging: botulinum toxin, fillers and mesotherapy]. Rev Laryngol Otol Rhinol (Bord), 2010. 131(2): p. 89-95.
  52. Babacan, T., et al., A case of the Behcet’s disease diagnosed by the panniculits after mesotherapy. Rheumatol Int, 2010. 30(12): p. 1657-9.
  53. Shaladi, A.M., et al., [Cervical lymphoadenopathy due to Pseudomonas aeruginosa following mesotherapy]. Infez Med, 2009. 17(3): p. 169-72.
  54. Regnier, S., et al., Clinical management of rapidly growing mycobacterial cutaneous infections in patients after mesotherapy. Clin Infect Dis, 2009. 49(9): p. 1358-64.
  55. Nabavi, C.B., D.S. Minckler, and J.P. Tao, Histologic features of mesotherapy-induced orbital fat inflammation. Ophthal Plast Reconstr Surg, 2009. 25(1): p. 69-70.
  56. Matarasso, A. and T.M. Pfeifer, Mesotherapy and injection lipolysis. Clin Plast Surg, 2009. 36(2): p. 181-92, v; discussion 193.
  57. Gokdemir, G., A. Kucukunal, and D. Sakiz, Cutaneous granulomatous reaction from mesotherapy. Dermatol Surg, 2009. 35(2): p. 291-3.
  58. Duque-Estrada, B., et al., Alopecia secondary to mesotherapy. J Am Acad Dermatol, 2009. 61(4): p. 707-9.
  59. Duncan, D., et al., Refinement of technique in injection lipolysis based on scientific studies and clinical evaluation. Clin Plast Surg, 2009. 36(2): p. 195-209, v-vi; discussion 211-3.
  60. Difonzo, E.M., et al., Mesotherapy and cutaneous Mycobacterium fortuitum infection. Int J Dermatol, 2009. 48(6): p. 645-7.
  61. Del-Castillo, M., et al., Mesotherapy-associated outbreak caused by Mycobacterium immunogenum. Emerg Infect Dis, 2009. 15(2): p. 357-9.
  62. Carbonne, A., et al., Outbreak of nontuberculous mycobacterial subcutaneous infections related to multiple mesotherapy injections. J Clin Microbiol, 2009. 47(6): p. 1961-4.
  63. Beer, K. and J. Waibel, Disfiguring scarring following mesotherapy-associated Mycobacterium cosmeticum infection. J Drugs Dermatol, 2009. 8(4): p.
    391-3.
  64. Wanner, M. and M. Avram, An evidence-based assessment of treatments for cellulite. J Drugs Dermatol, 2008. 7(4): p. 341-5.
  65. Viana-Niero, C., et al., Molecular characterization of Mycobacterium massiliense and Mycobacterium bolletii in isolates collected from outbreaks of infections after laparoscopic surgeries and cosmetic procedures. J Clin Microbiol, 2008. 46(3): p. 850-5.
  66. Strahan, J.E., J.L. Cohen, and J.A. Chorny, Granuloma annulare as a complication of mesotherapy: a case report. Dermatol Surg, 2008. 34(6): p. 836-8.
  67. Park, S.H., et al., Effectiveness of mesotherapy on body contouring. Plast Reconstr Surg, 2008. 121(4): p. 179e-85e.
  68. Olivero-Rivera, L., Mesotherapy for body sculpting. European staple of reshaping gaining ground here. Adv Nurse Pract, 2008. 16(11): p. 30.
  69. Munayco, C.V., et al., Outbreak of persistent cutaneous abscesses due to Mycobacterium chelonae after mesotherapy sessions, Lima, Peru. Rev Saude Publica, 2008. 42(1): p. 146-9.
  70. Lacarrubba, F., et al., Mesotherapy for skin rejuvenation: assessment of the subepidermal low-echogenic band by ultrasound evaluation with cross-sectional B-mode scanning. Dermatol Ther, 2008. 21 Suppl 3: p. S1-5.
  71. Kadry, R., et al., Multifocal scalp abscess with subcutaneous fat necrosis and scarring alopecia as a complication of scalp mesotherapy. J Drugs Dermatol, 2008. 7(1): p. 72-3.
  72. Garcia-Navarro, X., et al., Mycobacterium abscessus infection secondary to mesotherapy. Clin Exp Dermatol, 2008. 33(5): p. 658-9.
  73. Davis, M.D., T.I. Wright, and J.M. Shehan, A complication of mesotherapy: noninfectious granulomatous panniculitis. Arch Dermatol, 2008. 144(6): p. 808-9.
  74. Danilovic, D.L., et al., Factitious thyrotoxicosis induced by mesotherapy: a case report. Thyroid, 2008. 18(6): p. 655-7.
  75. Caruso, M.K., et al., An evaluation of mesotherapy solutions for inducing lipolysis and treating cellulite. J Plast Reconstr Aesthet Surg, 2008. 61(11): p. 1321-4.
  76. Atiyeh, B.S., A.E. Ibrahim, and S.A. Dibo, Cosmetic mesotherapy: between scientific evidence, science fiction, and lucrative business. Aesthetic Plast Surg, 2008. 32(6): p. 842-9.
  77. Al-Khenaizan, S., Facial cutaneous ulcers following mesotherapy. Dermatol Surg, 2008. 34(6): p. 832-4; discussion 834-5.
  78. Mesotherapy: mycobacteriosis. Complementary medicine can induce adverse effects. Prescrire Int, 2008. 17(94): p. 67.
  79. Vedamurthy, M., Mesotherapy. Indian J Dermatol Venereol Leprol, 2007. 73(1): p. 60-2.
  80. Sanudo, A., et al., Nontuberculous mycobacteria infection after mesotherapy: preliminary report of 15 cases. Int J Dermatol, 2007. 46(6): p. 649-53.
  81. Gamo, R., et al., Sporotrichosis following mesotherapy for arthrosis. Acta Derm Venereol, 2007. 87(5): p. 430-1.
  82. Doerr, T.D., Lipoplasty of the face and neck. Curr Opin Otolaryngol Head Neck Surg, 2007. 15(4): p. 228-32.
  83. Demirkan, F., et al., Mesotherapy: can it be a cause of perforator flap failure? Plast Reconstr Surg, 2007. 119(3): p. 1137-8.
  84. Co, A.C., M.F. Abad-Casintahan, and A. Espinoza-Thaebtharm, Submental fat reduction by mesotherapy using phosphatidylcholine alone vs. phosphatidylcholine and organic silicium: a pilot study. J Cosmet Dermatol, 2007. 6(4): p. 250-7.
  85. Tan, J. and B. Rao, Mesotherapy-induced panniculitis treated with dapsone: case report and review of reported adverse effects of mesotherapy. J Cutan Med Surg, 2006. 10(2): p. 92-5.
  86. Stachowski, J., et al., Mesotherapy: cosmetic applications. Int J Pharm Compd, 2006. 10(5): p. 331-4.
  87. Rotunda, A.M. and M.S. Kolodney, Mesotherapy and phosphatidylcholine injections: historical clarification and review. Dermatol Surg, 2006. 32(4): p. 465-80.
  88. Rivera-Olivero, I.A., et al., [Soft-tissue infections due to non-tuberculous mycobacteria following mesotherapy. What is the price of beauty]. Enferm Infecc Microbiol Clin, 2006. 24(5): p. 302-6.
  89. Lim, E.C. and R.C. Seet, Botulinum toxin injections to reduce adiposity: possibility, or fat chance? Med Hypotheses, 2006. 67(5): p. 1086-9.
  90. Colon-Soto, M., R.A. Peredo, and L.M. Vila, Systemic lupus erythematosus after mesotherapy with acetyl-L-carnitine. J Clin Rheumatol, 2006. 12(5): p. 261-2.
  91. Brown, S.A., The science of mesotherapy: chemical anarchy. Aesthet Surg J, 2006. 26(1): p. 95-8.
  92. Amin, S.P., R.G. Phelps, and D.J. Goldberg, Mesotherapy for facial skin rejuvenation: a clinical, histologic, and electron microscopic evaluation. Dermatol Surg, 2006. 32(12): p. 1467-72.
  93. Rotunda, A.M., M.M. Avram, and A.S. Avram, Cellulite: Is there a role for injectables? J Cosmet Laser Ther, 2005. 7(3-4): p. 147-54.
  94. Rose, P.T. and M. Morgan, Histological changes associated with mesotherapy for fat dissolution. J Cosmet Laser Ther, 2005. 7(1): p. 17-9.
  95. Rohrich, R.J., Mesotherapy: what is it? Does it work? Plast Reconstr Surg, 2005. 115(5): p. 1425.
  96. Matarasso, A., T.M. Pfeifer, and D.C. Plastic Surgery Educational Foundation, Mesotherapy for body contouring. Plast Reconstr Surg, 2005. 115(5): p. 1420-4.
  97. Lee, D.P. and S.E. Chang, Subcutaneous nodules showing fat necrosis owing to mesotherapy. Dermatol Surg, 2005. 31(2): p. 250-1.
  98. Henry, F., C. Pierard-Franchimont, and G.E. Pierard, [Clinical case of the month. Atypical mycobacteria and mesotherapy]. Rev Med Liege, 2005. 60(1): p. 7-10.
  99. Centers for Disease, C. and Prevention, Outbreak of mesotherapy-associated skin reactions–District of Columbia area, January-February 2005. MMWR Morb Mortal Wkly Rep, 2005. 54(44): p. 1127-30.
  100. Brandao, C., et al., Abdominal haematoma–a mesotherapy complication. Acta Derm Venereol, 2005. 85(5): p. 446.
  101. Bessis, D., J.J. Guilhou, and B. Guillot, Localized urticaria pigmentosa triggered by mesotherapy. Dermatology, 2004. 209(4): p. 343-4.
  102. Marco-Bonnet, J., et al., [Mycobacterial bovis BCG cutaneous infections following mesotherapy: 2 cases]. Ann Dermatol Venereol, 2002. 129(5 Pt 1): p. 728-31.
  103. Rosina, P., et al., Psoriasis and side-effects of mesotherapy. Int J Dermatol, 2001. 40(9): p. 581-3.
  104. Nagore, E., et al., Cutaneous infection with Mycobacterium fortuitum after localized microinjections (mesotherapy) treated successfully with a triple drug regimen. Acta Derm Venereol, 2001. 81(4): p. 291-3.
  105. Tennstedt, D. and J.M. Lachapelle, [Cutaneous adverse effects of mesotherapy]. Ann Dermatol Venereol, 1997. 124(2): p. 192-6.
  106. Doutre, M.S. and C. Beylot, [Side effects of mesotherapy]. Therapie, 1997. 52(2): p. 93-6.
  107. Grojean, M.F. and L. Vaillant, [Lichenoid eruption caused by mesotherapy]. Ann Med Interne (Paris), 1995. 146(5): p. 365-6.

 

update: june 2015